MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by AHybridofStreetandStocksmartson Apr 11, 2014 10:58am

161 Views

Post# 22439675

I am betting that the Chinese Conference will spark new

interest in MIR shares amongs potential Chinese investors. Having Medmira run by Chinese should also help...at this low price, it would allow millions of Chinese investors to invest in Medmira. I would not be surprised if Medmira went to .20 cents given this reason alone...

Bullboard Posts

Nvidia reports record revenue in Q3